Cite
APA Citation
Mueller, R., Gengenbacher, M., Richter, S., Dudler, J., Möller, B., & von Kempis, J. (2016). change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK). Arthritis research & therapy, 18(1), 1–6. http://access.bl.uk/ark:/81055/vdc_100080446697.0x000042